Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

3-hour genome sequencing and targeted analysis to rapidly assess genetic risk

Miranda Galey, Paxton Reed, Tara Wenger, Erika Beckman, Irene J. Chang, Cate R. Paschal, Jillian G. Buchan, Christina M. Lockwood, Mihai Puia-Dumitrescu, Daniel R. Garalde, Joseph Guillory, Androo J. Markham, Andrew B. Stergachis, Michael J. Bamshad, Evan E. Eichler, View ORCID ProfileDanny E. Miller
doi: https://doi.org/10.1101/2022.09.09.22279746
Miranda Galey
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paxton Reed
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara Wenger
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Beckman
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
MS, CGC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene J. Chang
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cate R. Paschal
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
3Department of Laboratories, Seattle Children’s Hospital, Seattle, WA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jillian G. Buchan
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina M. Lockwood
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
4Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA
5Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mihai Puia-Dumitrescu
6Division of Neonatology, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R. Garalde
7Oxford Nanopore Technologies, Oxford, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Guillory
7Oxford Nanopore Technologies, Oxford, UK
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Androo J. Markham
7Oxford Nanopore Technologies, Oxford, UK
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew B. Stergachis
4Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA
5Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, USA
8Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Bamshad
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
4Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA
5Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan E. Eichler
4Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA
5Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, USA
9Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danny E. Miller
1Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
2Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
5Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, WA, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danny E. Miller
  • For correspondence: dm1@uw.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Rapid genetic testing in the critical care setting enables targeted evaluations, directs therapies, and helps families and care providers make informed decisions about goals of care. We tested whether we could perform ultra-rapid assessment of genetic risk for a Mendelian condition, based on information from an affected sibling, in a newborn via whole-genome sequencing using the Oxford Nanopore platform. By optimization of the DNA extraction and library preparation steps paired with targeted analysis, we were able to demonstrate within three hours of birth that the newborn was neither affected nor a carrier for variants underlying acrodermatitis enteropathica. This proof-of-concept experiment demonstrates how prior knowledge of familial variants can be used to rapidly evaluate an individual at-risk for a genetic disease.

Competing Interest Statement

JG, AJM, and DRG are employees of Oxford Nanopore Technologies (ONT). DEM has received travel support from ONT to speak on their behalf. DEM and EEE are engaged in a research agreement with ONT. EEE is a scientific advisory board (SAB) member of Variant Bio, Inc. DEM holds stock options in MyOme.

Funding Statement

This work was supported, in part, by a trainee grant to DEM from the Brotman Baty Institute for Precision medicine, and a US National Institute of Mental Health (NIMH) grant R01MH101221 to EEE. EEE is an investigator of the Howard Hughes Medical Institute.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of the University of Washington gave ethical approval for this work. The legal representatives of both individuals described in this report consented to having the results of this research work published.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data that support the findings of this study are available upon request from the corresponding author. Additional clinical information about the individuals described here are available upon request from the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 13, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
3-hour genome sequencing and targeted analysis to rapidly assess genetic risk
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
3-hour genome sequencing and targeted analysis to rapidly assess genetic risk
Miranda Galey, Paxton Reed, Tara Wenger, Erika Beckman, Irene J. Chang, Cate R. Paschal, Jillian G. Buchan, Christina M. Lockwood, Mihai Puia-Dumitrescu, Daniel R. Garalde, Joseph Guillory, Androo J. Markham, Andrew B. Stergachis, Michael J. Bamshad, Evan E. Eichler, Danny E. Miller
medRxiv 2022.09.09.22279746; doi: https://doi.org/10.1101/2022.09.09.22279746
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
3-hour genome sequencing and targeted analysis to rapidly assess genetic risk
Miranda Galey, Paxton Reed, Tara Wenger, Erika Beckman, Irene J. Chang, Cate R. Paschal, Jillian G. Buchan, Christina M. Lockwood, Mihai Puia-Dumitrescu, Daniel R. Garalde, Joseph Guillory, Androo J. Markham, Andrew B. Stergachis, Michael J. Bamshad, Evan E. Eichler, Danny E. Miller
medRxiv 2022.09.09.22279746; doi: https://doi.org/10.1101/2022.09.09.22279746

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1955)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11118)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3192)
  • Geriatric Medicine (309)
  • Health Economics (565)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (788)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12738)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2999)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1560)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5609)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (764)
  • Rheumatology (340)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)